BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

7.92
Delayed Data
As of Apr 18
 +0.23 / +2.99%
Today’s Change
4.76
Today|||52-Week Range
9.95
-1.86%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close7.69
Today’s open7.71
Day’s range7.56 - 7.96
Volume1,133,049
Average volume (3 months)780,420
Market cap$874.4M
Data as of 4:00pm ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)-25.81%
Earnings growth (this year)-20.75%
Earnings growth (next 5 years)+19.86%
Revenue growth (last year)-18.00%
P/E ratioNM
Price/Sales40.32
Price/Book17.73

Competitors

 Today’s
change
Today’s
% change
EIDXEidos Therapeutics I...+0.20+0.86%
DCPHDeciphera Pharmaceut...+0.48+2.09%
RYTMRhythm Pharmaceutica...+0.83+3.27%
TWSTTwist Bioscience Cor...+1.42+4.99%
Data as of 4:00pm ET, 04/18/2019

Financials

Next reporting dateMay 7, 2019
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$20.7M
Annual profit (last year)-$101.3M
Net profit margin-490.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts